Patents by Inventor Phillip Low

Phillip Low has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USING AUTOLOGOUS MESENCHYMAL STEM CELLS TO TREAT MULTIPLE SYSTEM ATROPHY
    Publication number: 20250017976
    Abstract: This document provides methods and materials for treating multiple system atrophy. For example, methods and materials for using autologous mesenchymal stem cells (e.g., adipose derived mesenchymal stem cells) to treat multiple system atrophy are provided.
    Type: Application
    Filed: September 27, 2024
    Publication date: January 16, 2025
    Inventors: Wolfgang Singer, Phillip Low
  • Using autologous mesenchymal stem cells to treat multiple system atrophy
    Patent number: 12133869
    Abstract: This document provides methods and materials for treating multiple system atrophy. For example, methods and materials for using autologous mesenchymal stem cells (e.g., adipose derived mesenchymal stem cells) to treat multiple system atrophy are provided.
    Type: Grant
    Filed: June 23, 2023
    Date of Patent: November 5, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Wolfgang Singer, Phillip Low
  • USING AUTOLOGOUS MESENCHYMAL STEM CELLS TO TREAT MULTIPLE SYSTEM ATROPHY
    Publication number: 20240100097
    Abstract: This document provides methods and materials for treating multiple system atrophy. For example, methods and materials for using autologous mesenchymal stem cells (e.g., adipose derived mesenchymal stem cells) to treat multiple system atrophy are provided.
    Type: Application
    Filed: June 23, 2023
    Publication date: March 28, 2024
    Inventors: Wolfgang Singer, Phillip Low
  • Using autologous mesenchymal stem cells to treat multiple system atrophy
    Patent number: 11723928
    Abstract: This document provides methods and materials for treating multiple system atrophy. For example, methods and materials for using autologous mesenchymal stem cells (e.g., adipose derived mesenchymal stem cells) to treat multiple system atrophy are provided.
    Type: Grant
    Filed: August 12, 2022
    Date of Patent: August 15, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Wolfgang Singer, Phillip Low
  • USING AUTOLOGOUS MESENCHYMAL STEM CELLS TO TREAT MULTIPLE SYSTEM ATROPHY
    Publication number: 20230075604
    Abstract: This document provides methods and materials for treating multiple system atrophy. For example, methods and materials for using autologous mesenchymal stem cells (e.g., adipose derived mesenchymal stem cells) to treat multiple system atrophy are provided.
    Type: Application
    Filed: August 12, 2022
    Publication date: March 9, 2023
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Wolfgang Singer, Phillip Low
  • Using autologous mesenchymal stem cells to treat multiple system atrophy
    Patent number: 11426431
    Abstract: This document provides methods and materials for treating multiple system atrophy in a mammal. Specifically, the methods comprises intrathecally administering to the mammal a composition comprising autologous mesenchymal stem cells (e.g. adipose deprived mesenchymal stem cells) to treat multiple system atrophy. Further disclosed is the composition comprising from about 5×10(6) to about 5×10(8) autologous mesenchymal stem cells.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: August 30, 2022
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Wolfgang Singer, Phillip Low
  • USING AUTOLOGOUS MESENCHYMAL STEM CELLS TO TREAT MULTIPLE SYSTEM ATROPHY
    Publication number: 20180161374
    Abstract: This document provides methods and materials for treating multiple system atrophy in a mammal. Specifically, the methods comprises intrathecally administering to the mammal a composition comprising autologous mesenchymal stem cells (e.g. adipose deprived mesenchymal stem cells) to treat multiple system atrophy. Further disclosed is the composition comprising from about 5×10(6) to about 5×10(8) autologous mesenchymal stem cells.
    Type: Application
    Filed: June 15, 2016
    Publication date: June 14, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Wolfgang Singer, Phillip Low